These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9569026

  • 21. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.
    Xiang J, Gómez-Navarro J, Arafat W, Liu B, Barker SD, Alvarez RD, Siegal GP, Curiel DT.
    J Gene Med; 2000; 2(2):97-106. PubMed ID: 10809143
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
    Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M.
    Cancer Res; 2001 Feb 15; 61(4):1699-706. PubMed ID: 11245486
    [Abstract] [Full Text] [Related]

  • 23. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
    Brown DM, Phipps RP.
    J Immunol; 1996 Aug 15; 157(4):1359-70. PubMed ID: 8759715
    [Abstract] [Full Text] [Related]

  • 24. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
    Kang KH, Kim WH, Choi KH.
    Exp Cell Res; 1999 Dec 15; 253(2):403-12. PubMed ID: 10585263
    [Abstract] [Full Text] [Related]

  • 25. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.
    Mol Pharmacol; 1994 Oct 15; 46(4):605-11. PubMed ID: 7969039
    [Abstract] [Full Text] [Related]

  • 26. Dimerization of mitochondrial Bax is associated with increased drug response in Bax-transfected A253 cells.
    Guo B, Yin MB, Tóth K, Cao S, Azrak RG, Rustum YM.
    Oncol Res; 1999 Oct 15; 11(2):91-9. PubMed ID: 10489165
    [Abstract] [Full Text] [Related]

  • 27. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER, Piché L, Lemieux G, Lemieux R.
    Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839
    [Abstract] [Full Text] [Related]

  • 28. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.
    Jia L, Patwari Y, Kelsey SM, Newland AC.
    Biochem Biophys Res Commun; 2001 May 25; 283(5):1037-45. PubMed ID: 11355877
    [Abstract] [Full Text] [Related]

  • 29. [Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide].
    Meliksetian MB, Berezkina EV, Pavlenko MA, Grinchuk TM.
    Tsitologiia; 1999 May 25; 41(7):615-21. PubMed ID: 10496023
    [Abstract] [Full Text] [Related]

  • 30. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6318-25. PubMed ID: 11103792
    [Abstract] [Full Text] [Related]

  • 31. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
    Liu Y, Xie KM, Yang GQ, Bai XM, Shi YP, Mu HJ, Qiao WZ, Zhang B, Xie P.
    Cancer Chemother Pharmacol; 2010 Aug 15; 66(3):433-9. PubMed ID: 19936984
    [Abstract] [Full Text] [Related]

  • 32. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL.
    Clin Cancer Res; 1999 Feb 15; 5(2):361-9. PubMed ID: 10037186
    [Abstract] [Full Text] [Related]

  • 33. Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation.
    Kobayashi T, Sawa H, Morikawa J, Ueno S, Katayama N, Zhang W, Shiku H.
    Int J Oncol; 2002 Apr 15; 20(4):723-8. PubMed ID: 11894116
    [Abstract] [Full Text] [Related]

  • 34. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.
    Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630
    [Abstract] [Full Text] [Related]

  • 35. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA.
    Mol Ther; 2000 Jun 09; 1(6):545-54. PubMed ID: 10933979
    [Abstract] [Full Text] [Related]

  • 36. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 09; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 37. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins.
    Choi WS, Canzoniero LM, Sensi SL, O'Malley KL, Gwag BJ, Sohn S, Kim JE, Oh TH, Lee EB, Oh YJ.
    Exp Neurol; 1999 Sep 09; 159(1):274-82. PubMed ID: 10486196
    [Abstract] [Full Text] [Related]

  • 38. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors.
    Ishibashi Y, Nishimaki K, Asoh S, Nanbu-Wakao R, Yamada T, Ohta S.
    Biochem Biophys Res Commun; 1998 Feb 13; 243(2):609-16. PubMed ID: 9480856
    [Abstract] [Full Text] [Related]

  • 39. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC, Li Q, Chu W, Zochodne B, Kapoor M, Ung Y, Rosen K, Ben-David Y.
    Oncogene; 2001 Apr 26; 20(18):2291-300. PubMed ID: 11402324
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, Arnold W, Dietel M, Guski H, Feller A, Royer HD, Dörken B.
    J Clin Invest; 1996 Jun 01; 97(11):2651-9. PubMed ID: 8647960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.